dmp 323 has been researched along with xk 263 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldrich, PE; Bacheler, LT; Chang, CH; Confalone, PN; Daneker, WF; DeLucca, GV; Emmett, G; Eyermann, CJ; Han, Q; Hodge, CN; Holler, ER; Jadhav, PK; Klabe, RM; Kornhauser, DM; Lam, PY; Li, L; Li, R; Markwalder, JA; McHugh, RJ; Rayner, MM; Ru, Y; Seitz, SP; Sharpe, TR; Shum, L; Winslow, DL | 1 |
| Bacheler, LT; Calabrese, JC; Chang, CH; Daneker, WF; Erickson-Viitanen, S; Eyermann, CJ; Hodge, CN; Jackson, DA; Jadhav, PK; Lam, PY; Man, HW; Meek, JL; Rayner, MM; Schadt, M; Woerner, FJ | 1 |
| Bacheler, LT; Cordova, B; De Lucca, GV; Erickson-Viitanen, S; Garber, S; Kim, UT; Klabe, RM; Ko, SS; Lam, GN; Liang, J; Logue, KA; Trainor, GL; Wright, MR | 1 |
| Debnath, AK | 1 |
4 other study(ies) available for dmp 323 and xk 263
| Article | Year |
|---|---|
Cyclic HIV protease inhibitors: synthesis, conformational analysis, P2/P2' structure-activity relationship, and molecular recognition of cyclic ureas.
Topics: Animals; HIV Protease Inhibitors; Humans; Molecular Conformation; Structure-Activity Relationship; Urea | 1996 |
Nonpeptide cyclic cyanoguanidines as HIV-1 protease inhibitors: synthesis, structure-activity relationships, and X-ray crystal structure studies.
Topics: Anti-HIV Agents; Cell Line; Crystallography, X-Ray; Guanidines; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Hydrogen Bonding; Models, Molecular; Structure-Activity Relationship; Urea | 1998 |
Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Azepines; Biological Availability; Cell Line; Chromatography, High Pressure Liquid; Dogs; Drug Design; Drug Resistance, Microbial; HIV Protease Inhibitors; HIV-1; Indazoles; Mutation; Ritonavir; RNA, Viral; Structure-Activity Relationship; Transcription, Genetic; Urea | 1998 |
Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis.
Topics: Anti-HIV Agents; Crystallography, X-Ray; HIV Protease Inhibitors; Models, Molecular; Structure-Activity Relationship; Urea | 1999 |